MarketCap
Profound Medical Corp. PROF
$ 7.26
5.99%
Facebook
X
Telegram
Profound Medical Corp. Total Shareholders Equity | PROF
Annual Total Shareholders Equity Profound Medical Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.4 M | 60.4 M | 31.2 M | 52.6 M | - | 97.4 M | 14.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.4 M | 14.4 M | 53.7 M |
Quarterly Total Shareholders Equity Profound Medical Corp.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.4 M | 32.1 M | 39.3 M | 50.8 M | 31.2 M | - | - | - | - | 80.6 M | - | - | - | 97.4 M | - | - | - | 14.4 M | - | - | - | 19.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 97.4 M | 14.4 M | 47.2 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | - | - | $ 162 M |  France |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
638 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
LENSAR
LNSR
|
-26 M | $ 5.6 | -2.78 % | $ 67 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | USA |
 |
Outset Medical
OM
|
127 M | $ 4.04 | -4.49 % | $ 61.5 K | USA |
 |
AxoGen
AXGN
|
129 M | $ 39.49 | -0.6 % | $ 1.82 B | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 163.26 | 3.08 % | $ 11.5 B | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Quanterix Corporation
QTRX
|
296 M | $ 3.67 | -6.38 % | $ 156 M | USA |
 |
Bruker Corporation
BRKR
|
2.46 B | $ 60.45 | -2.74 % | $ 9.18 B | USA |
 |
Sintx Technologies
SINT
|
2.93 M | $ 1.42 | -6.58 % | $ 3.94 M | USA |
 |
TELA Bio
TELA
|
6.31 M | $ 0.69 | -2.81 % | $ 32.4 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 27.48 | 0.15 % | $ 629 M | USA |
 |
TransMedics Group
TMDX
|
473 M | $ 72.26 | 1.59 % | $ 2.46 B | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 0.89 | -3.38 % | $ 15.1 M | USA |
 |
Tandem Diabetes Care
TNDM
|
155 M | $ 17.12 | 1.3 % | $ 1.16 B | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 14.12 | -2.55 % | $ 400 M | USA |
 |
Viemed Healthcare
VMD
|
142 M | $ 11.77 | 0.86 % | $ 458 M | USA |
 |
Avanos Medical
AVNS
|
778 M | $ 24.99 | 0.04 % | $ 1.16 B | USA |
 |
Beyond Air
XAIR
|
6.13 M | $ 5.16 | -5.67 % | $ 42.8 B | USA |
 |
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
51 M | $ 0.43 | -0.39 % | $ 60 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.36 | -0.39 % | $ 22.4 M | USA |
 |
NanoVibronix
NAOV
|
33.5 M | - | - | $ 1.08 M | USA |
 |
NuVasive
NUVA
|
869 M | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
425 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
231 M | - | - | $ 217 M | USA |
 |
Inogen
INGN
|
192 M | $ 6.15 | -2.69 % | $ 164 M | USA |